Datroway: 37% Reduction In The Risk Of Death VS Chemotherapy
Based on the TROPION-Breast01 trial, Daiichi Sankyo and AstraZeneca’s DATROWAY was approved for the first…
News
6 Must-Know Facts About Briviact for Partial-Onset Seizures
Epilepsy is a chronic neurological disorder that affects an estimated 65 million people worldwide. Briviact…
Akynzeo Capsule | One Capsule, Dual Protection
Akynzeo capsule is an FDA-approved antiemetic medication specifically designed to address both acute and delayed…
Discover Briumvi Uses, Dosage, and Side Effects
NEW YORK, April 8, 2025 (GLOBE NEWSWIRE) — TG Therapeutics, Inc.(TGTX) announced today that it…
Cobenfy: A New Frontier In Schizophrenia Treatment Faces Early Challenges
In September 2024, the U.S. Food and Drug Administration (FDA) approved Cobenfy (xanomeline and trospium…
Why Is Auvelity The Future Of Depression Care?
Major depressive disorder (MDD) has been ranked as the third cause of the burden of…
Flyrcado™ : A Breakthrough In Cardiac PET Imaging For Coronary Artery Disease
In a landmark advancement for nuclear cardiology, GE HealthCare has launched Flyrcado™ (flurpiridaz F 18), the first FDA-approved unit-dose…
FDA Approves Itovebi: A New Targeted Therapy For Advanced Breast Cancer
The U.S. Food and Drug Administration (FDA) has approved Itovebi™ (inavolisib), developed by Genentech, a…
Orlynvah Offers Hope Amid Rising Antibiotic Resistance In UTI Treatments
In October 2024, the U.S. Food and Drug Administration (FDA) approved Orlynvah™ (sulopenem etzadroxil and…
Ziihera: A New Hope For HER2-Positive Biliary Tract Cancer Patients
In November 2024, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Ziihera®…
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights